grocery glp-1 news How weight-loss drugs are destroying big snacking, erasing billions in sales — TradingView GLP-1 Receptor Agonist Market Growth

September 21, 2025: Litigation focus continues to shift from gastroparesis claims, which have faced challenges in demonstrating direct causation versus diabetes complications, toward vision loss cases involving non-arteritic anterior ischemic optic neuropathy (NAION)

Key benefits: Helps reduce food intake and emotional eating Promotes 10-15% average body weight loss Lowers blood sugar and supports cardiovascular health Administered weekly by injection Learn more about semaglutide and how it works Tirzepatide Tirzepatide is a next-generation medication that stimulates both GLP-1 and GIP receptors, delivering enhanced metabolic effects

The most prominent theory is that GLP-1 medications may sensitize the cutaneous nerves, which are the nerves responsible for sensations in your skin

Alcoholism, clinical and experimental research, 40(12), 24742481

Barie PS, Eachempati SR (2010) Acute acalculous cholecystitis